- Published at
- by gurufocus.com
mixed
mixed
News for Advaxis, Inc. (ADXS)
- Published at
- by gurufocus.com
mixedmixedDiaMedica Therapeutics Appoints Daniel J. O'Connor to the Board of Directors
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on acute ischemic stroke and preeclampsia, today announced the e- Published at
- by gurufocus.com
mixedmixedAdvaxis (ADXS) Sees 112.96% Surge Amid Market Volatility
Advaxis, Inc. (ADXS), traded on the U.S. OTC market, recently experienced significant stock price volatility with a remarkable increase of 112.96%. The stock is- Published at
- by gurufocus.com
mixedmixedAdvaxis (ADXS) Stock Plummets by 74% Amidst Market Fluctuations
Advaxis, Inc. (ADXS), a company trading on the U.S. OTC market, experienced a significant stock price drop of 74.31%. The current trading price of ADXS stands a- Published at
- by globenewswire.com
negativenegativeMetastatic Prostate Cancer Clinical Trial Pipeline Insights Featuring 75+ Companies | DelveInsight
The metastatic prostate cancer market is driven by advancements in targeted therapies and immunotherapies, catering to a growing aging population. Early...- Published at
- by gurufocus.com
positivepositiveAdvaxis Inc Extraordinary Shareholders Meeting Transcript
Jan 13, 2023 / 03:00PM GMTOperator Good day, and welcome to the Advaxis, Inc. 2023 special meeting. I would now like to turn the conference over to Kenneth Berl- Published at
- by gurufocus.com
positivepositiveBiosight Ltd and Advaxis Inc to Discuss Proposed Transaction Call Transcript
Jul 06, 2021 / 12:30PM GMTOperator Greetings, and welcome to the Advaxis and Biosight merger announcement. (Operator Instructions) As a reminder, this conferenc- Published at
- by gurufocus.com
neutralneutralAdvaxis Inc Webinar in Biotech and Specialty Pharma Hosted By Alliance Global Partners Transcript
Jun 29, 2020 / 03:00PM GMTJames Francis Molloy - Alliance Global Partners, Research Division - MD of Equity Research and Biotechnology & Specialty Pharmaceutica- Published at
- by gurufocus.com
positivepositiveAdvaxis Inc Annual Shareholders Meeting Transcript
May 04, 2020 / 02:00PM GMTOperator Ladies and gentlemen, thank you for standing by, and welcome to the 2020 Event -- Annual Meeting of Stockholders. (Operator I- Published at
- by globenewswire.com
mixedmixedNeoantigen Cancer Vaccine Market Size is Projected to Reach $1.38 billion by 2030: Straits Research
The growth of the market for Neoantigen cancer vaccines is primarily attributable to rapid technological advancements and improvements in the healthcare...- Published at
- by globenewswire.com
neutralneutralAyala Pharmaceuticals Announces Closing of Merger with Biosight
REHOVOT, Israel & MONMOUTH JUNCTION, N.J., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage oncology...- Published at
- by globenewswire.com
positivepositiveCervical Dysplasia Treatment Market to Achieve US$ 846.2 Million Valuation by 2033 | Future Market Insights Inc.
Innovative cervical dysplasia treatments drive market growth, backed by government programs & patient demand....- Published at
- by globenewswire.com
mixedmixedNew Innovations opens Prospects for the Cancer Vaccine Market, Propelling the Growth of Market at 12% CAGR through 2033 | Future Market Insights, Inc. Study
The recombinant cancer vaccines segment accounts for the largest market share. North America is expected to possess 40% market share for the Cancer...- Published at
- by marketscreener.com
mixedmixedAyala Pharmaceuticals : Merger Agreement - Form 8-K
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ... | January 4, 2023- Published at
- by prnewswire.com
mixedmixedCancer Vaccines Market Research Report by Technology, Treatment Method, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
/PRNewswire/ -- Cancer Vaccines Market Research Report by Technology, Treatment Method, Application, Region - Global Forecast to 2027 - Cumulative Impact of...- Published at
- by prnewswire.com
mixedmixedCervical Cancer Diagnostic Market is Prospering at 15.94 Billion Globally by 2029, Size, Share, Emerging Trends, Key Growth Factors, Demand and Competitive Outlook
/PRNewswire/ -- Data Bridge Market Research has recently published a Report, titled, "Cervical Cancer Diagnostic Market" The report offers an extensive...- Published at
- by etfdailynews.com
positivepositiveAnalysts’ New Coverage for May 24th (AAMC, AAU, ACU, ADXS, ALDX, APLD, AUMN, AZN, CFTLF, CRBP)
Read Analysts’ New Coverage for May 24th (AAMC, AAU, ACU, ADXS, ALDX, APLD, AUMN, AZN, CFTLF, CRBP) at ETF Daily News- Published at
- by benzinga.com
mixedmixedDelisting of Securities of China XD Plastics Company Limited and Advaxis, Inc. from The Nasdaq Stock Market
NEW YORK, Feb. 08, 2022 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of China XD Plastics Company Limited. China XD Plastics Company Limited's common stock was- Published at
- by globenewswire.com
mixedmixedCervical Cancer Pipeline Offers Promising New Options for Treatment | DelveInsight
The current chemotherapy-dominated landscape of cervical cancer treatment is set to change to include multiple different drug classes. ...- Published at
- by pennystocks.com
positivepositiveTop Penny Stocks to Buy From TikTok? 3 That Investors Are Watching
These penny stocks are popular on TikTok, are they on your watchlist?